2023
DOI: 10.1016/j.tcb.2022.04.011
|View full text |Cite
|
Sign up to set email alerts
|

The heterogeneity of cellular senescence: insights at the single-cell level

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
90
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 137 publications
(93 citation statements)
references
References 45 publications
3
90
0
Order By: Relevance
“…To our knowledge, this study presents the first depiction of the senescence phenotype at the single cell multiomic level (scRNA + scATAC). We believe our characterized gene and enhancer signatures will help pave the way toward a universal marker set of senescence, which is currently outstanding (Cohn et al, 2022; Gorgoulis et al, 2019). Using these single-cell senescent profiles along with their eGRN signatures, we can already show here a close proximity between the senescence phenotype and oncogenic programs, mostly due to the shared upregulation of C/EBP transcription factors activity.…”
Section: Discussionmentioning
confidence: 99%
“…To our knowledge, this study presents the first depiction of the senescence phenotype at the single cell multiomic level (scRNA + scATAC). We believe our characterized gene and enhancer signatures will help pave the way toward a universal marker set of senescence, which is currently outstanding (Cohn et al, 2022; Gorgoulis et al, 2019). Using these single-cell senescent profiles along with their eGRN signatures, we can already show here a close proximity between the senescence phenotype and oncogenic programs, mostly due to the shared upregulation of C/EBP transcription factors activity.…”
Section: Discussionmentioning
confidence: 99%
“…The generation of additional reporters into different loci, e.g. cdkn2a/b or other senescent markers will also allow to address the possible heterogeneity of senescent cells 46 .…”
Section: Discussionmentioning
confidence: 99%
“…Heterogeneity in the behavior and response of cancer cells is now well established (Dagogo-Jack & Shaw, 2018; Melo, Vermeulen, Fessler, & Medema, 2013), and recent work indicates a similar heterogeneity is present within senescent cells (Cohn, Gasek, Kuchel, & Xu, 2022). In this regard, it is interesting that we observed heterogeneity in the proliferative response of U2OS and OVCAR-8 cells following JNK and Mek inhibition in response to treatment with 0.5 µM doxorubicin, with only a fraction of the inhibitor-treated cells escaping from senescence onset.…”
Section: Discussionmentioning
confidence: 99%